Dr. Lawrence Morton, M.D
NPI: 1033138698
Total Payments
$18,055
2024 Payments
$2,261
Companies
17
Transactions
129
Medicare Patients
305
Medicare Billing
$40,193
Payment Breakdown by Category
Food & Beverage$5,380 (29.8%)
Consulting$5,304 (29.4%)
Other$5,219 (28.9%)
Travel$2,135 (11.8%)
Education$16.72 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,380 | 112 | 29.8% |
| Consulting Fee | $5,304 | 3 | 29.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,929 | 4 | 21.8% |
| Travel and Lodging | $2,135 | 8 | 11.8% |
| Honoraria | $1,290 | 1 | 7.1% |
| Education | $16.72 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurelis, Inc. | $6,541 | 14 | $0 (2024) |
| Greenwich Biosciences, Inc. | $4,197 | 5 | $0 (2020) |
| UCB, Inc. | $1,956 | 59 | $0 (2024) |
| LivaNova USA, Inc. | $1,322 | 13 | $0 (2023) |
| NOBELPHARMA AMERICA, LLC | $1,290 | 1 | $0 (2024) |
| Eisai Inc. | $1,157 | 12 | $0 (2021) |
| SK Life Science, Inc. | $580.32 | 6 | $0 (2023) |
| UPSHER-SMITH LABORATORIES LLC | $214.60 | 5 | $0 (2021) |
| BioMarin Pharmaceutical Inc. | $153.11 | 3 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $136.34 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,261 | 20 | NOBELPHARMA AMERICA, LLC ($1,290) |
| 2023 | $6,955 | 28 | Neurelis, Inc. ($6,253) |
| 2022 | $607.03 | 14 | UCB, Inc. ($414.62) |
| 2021 | $687.47 | 10 | SK Life Science, Inc. ($395.94) |
| 2020 | $1,669 | 4 | Greenwich Biosciences, Inc. ($1,579) |
| 2019 | $4,413 | 23 | Greenwich Biosciences, Inc. ($2,618) |
| 2018 | $934.32 | 18 | LivaNova USA, Inc. ($728.31) |
| 2017 | $528.99 | 12 | LivaNova USA, Inc. ($154.07) |
All Payment Transactions
129 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $145.95 | General |
| Category: EPILEPSY | ||||||
| 12/09/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $90.13 | General |
| 12/06/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $98.25 | General |
| 09/04/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Education | Cash or cash equivalent | $16.72 | General |
| Category: NEUROLOGY | ||||||
| 06/28/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $29.01 | General |
| Category: Neurology | ||||||
| 06/03/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $134.65 | General |
| Category: Neurology | ||||||
| 05/07/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $29.97 | General |
| Category: Neurology | ||||||
| 04/30/2024 | Alexion Pharmaceuticals, Inc. | KOSELUGO (Drug) | Food and Beverage | In-kind items and services | $134.43 | General |
| Category: Oncology | ||||||
| 04/12/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $32.07 | General |
| Category: Neurology | ||||||
| 04/02/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Neurology | ||||||
| 03/12/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $3.21 | General |
| Category: Neurology | ||||||
| 03/12/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $2.49 | General |
| Category: Neurology | ||||||
| 03/11/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Neurology | ||||||
| 03/11/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $2.17 | General |
| Category: Neurology | ||||||
| 03/05/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $121.65 | General |
| Category: EPILEPSY | ||||||
| 02/21/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: Neurology | ||||||
| 01/26/2024 | NOBELPHARMA AMERICA, LLC | HYFTOR (Drug) | Honoraria | Cash or cash equivalent | $1,290.00 | General |
| Category: Dermatology | ||||||
| 01/26/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Neurology | ||||||
| 01/25/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Neurology | ||||||
| 01/25/2024 | ACADIA Pharmaceuticals Inc | DAYBUE (Drug) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: RETT SYNDROME | ||||||
| 12/20/2023 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: Neurology | ||||||
| 12/03/2023 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $73.87 | General |
| Category: Neurology | ||||||
| 12/02/2023 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $103.04 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/16/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $28.90 | General |
| Category: Neurology | ||||||
| 10/19/2023 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $2.97 | General |
| Category: EPILEPSY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 46 | 53 | $36,491 | $6,071 |
| 2022 | 4 | 60 | 66 | $35,482 | $6,271 |
| 2021 | 3 | 73 | 93 | $66,627 | $11,218 |
| 2020 | 4 | 126 | 153 | $92,861 | $16,633 |
Total Patients
305
Total Services
365
Medicare Billing
$40,193
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 21 | 27 | $25,198 | $4,201 | 16.7% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2023 | 13 | 14 | $8,449 | $1,347 | 15.9% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 12 | 12 | $2,844 | $522.12 | 18.4% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2022 | 16 | 22 | $20,372 | $3,489 | 17.1% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2022 | 13 | 13 | $7,787 | $1,382 | 17.7% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 19 | 19 | $4,503 | $856.29 | 19.0% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2022 | 12 | 12 | $2,820 | $544.42 | 19.3% |
| 95720 | Continuous measurement of brain wave activity with video (veeg), 12-26 hours, with health care professional analysis, interpretation and report | Facility | 2021 | 33 | 50 | $46,300 | $7,881 | 17.0% |
| 95718 | Continuous measurement of brain wave activity with video (veeg), 2-12 hours, with health care professional analysis, interpretation and report | Facility | 2021 | 25 | 28 | $16,772 | $2,737 | 16.3% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2021 | 15 | 15 | $3,555 | $599.56 | 16.9% |
| 95720 | Continuous measurement of brain wave activity with video (veeg), 12-26 hours, with health care professional analysis, interpretation and report | Facility | 2020 | 43 | 68 | $62,050 | $10,900 | 17.6% |
| 95718 | Continuous measurement of brain wave activity with video (veeg), 2-12 hours, with health care professional analysis, interpretation and report | Facility | 2020 | 29 | 31 | $18,299 | $3,403 | 18.6% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2020 | 30 | 30 | $6,970 | $1,185 | 17.0% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Facility | 2020 | 24 | 24 | $5,542 | $1,146 | 20.7% |
About Dr. Lawrence Morton, M.D
Dr. Lawrence Morton, M.D is a Neurology with Special Qualifications in Child Neurology healthcare provider based in Richmond, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033138698.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lawrence Morton, M.D has received a total of $18,055 in payments from pharmaceutical and medical device companies, with $2,261 received in 2024. These payments were reported across 129 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($5,380).
As a Medicare-enrolled provider, Morton has provided services to 305 Medicare beneficiaries, totaling 365 services with total Medicare billing of $40,193. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology with Special Qualifications in Child Neurology
- Location Richmond, VA
- Active Since 07/18/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084N0402X
- Entity Type Individual
- NPI Number 1033138698
Products in Payments
- VALTOCO (Drug) $6,541
- Epidiolex (Drug) $4,197
- HYFTOR (Drug) $1,290
- VNS Therapy (Device) $1,219
- Fycompa (Drug) $1,157
- Briviact (Drug) $940.27
- Fintepla (Drug) $389.40
- XCOPRI (Drug) $207.38
- AFINITOR (Drug) $136.34
- KOSELUGO (Drug) $134.43
- ROSA Brain (Device) $109.39
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) $103.04
- VIGADRONE (vigabatrin) for Oral Solution (Drug) $102.15
- RNS System (Device) $90.84
- Nayzilam (Drug) $90.10
- VIGADRONE (Drug) $83.09
- ZTALMY (Drug) $82.50
- ACTHAR (Biological) $51.92
- Vimizim (Biological) $43.20
- QUDEXY XR Topiramate Extended Release Capsules (Drug) $29.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology with Special Qualifications in Child Neurology Doctors in Richmond
Dr. Mathula Thangarajh, Md, Phd, MD, PHD
Neurology with Special Qualifications in Child Neurology — Payments: $48,209
Neurology with Special Qualifications in Child Neurology $48,209
Dr. Amy Harper, M.d, M.D
Neurology with Special Qualifications in Child Neurology — Payments: $44,799
Neurology with Special Qualifications in Child Neurology $44,799
Donald Taylor, M.d, M.D
Neurology with Special Qualifications in Child Neurology — Payments: $468.24
Neurology with Special Qualifications in Child Neurology $468.24
Dr. Jean Teasley
Neurology with Special Qualifications in Child Neurology — Payments: $43.19
Neurology with Special Qualifications in Child Neurology $43.19
Christopher Henry, Md, MD
Neurology with Special Qualifications in Child Neurology
Neurology with Special Qualifications in Child Neurology
Miranda Creasey, Md, MD
Neurology with Special Qualifications in Child Neurology
Neurology with Special Qualifications in Child Neurology